Sign Out
As glycine is present in the formulation, Remifentanil is contraindicated for epidural and intrathecal use (see Pharmacology: Toxicology: Preclinical safety data under Actions).
Remifentanil is contraindicated in patients with known hypersensitivity to remifentanil and other fentanyl analogues or any other component of the preparation.
Remifentanil is contra-indicated for use as the sole agent for induction of anaesthesia.
